Obstetrics & Gynecology, Gynecologic Oncology · West Reading, PA
NPI
1447201827
Since 2006
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
6th Avenue and Spruce Street, N Bldg Ground Floor
West Reading, PA, 19611
Phone (610) 988-8905
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
591 services
Medicare patients, 2024
188
Average age 74
Drug cost, 2024
$1.7M
508 prescriptions
Company payments, 2025
$27.66
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John B Villeneuve was code 99213 (office e&m - established), 249 times for 147 patients. In total John B Villeneuve billed 591 services in 31 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 249 | 147 | $42.72 | $11K |
| 99214 Office E&M - Established | Facility | 179 | 30 | $70.51 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 16 | $60.28 | $3,135 |
| 99204 Office E&M - New | Facility | 27 | 27 | $98.08 | $2,648 |
| 99222 Hospital E&M - Initial | Facility | 12 | 11 | $99.76 | $1,197 |
By year: 2022 $44K for 499 services; 2023 $55K for 526 services; 2024 $56K for 591 services.
Medicare prescription drug claims, 2024
In 2024, the drug John B Villeneuve prescribed most often to Medicare patients was Zejula (Niraparib Tosylate), with 96 prescriptions and refills. In total John B Villeneuve wrote 508 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zejula Niraparib Tosylate | 96 | 96 | 12 | $1.6M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 58 | 58 | 37 | $331 |
| Prochlorperazine Maleate Generic | 56 | 56 | 27 | $558 |
| Anastrozole Generic | 39 | 69 | Under 11 | $895 |
| Clobetasol Propionate Generic | 31 | 31 | 13 | $1,077 |
| Enoxaparin Sodium Generic | 27 | 27 | 26 | $3,742 |
| Ondansetron Hcl Generic | 24 | 24 | 14 | $135 |
| Ondansetron Odt Ondansetron | 21 | 21 | 13 | $232 |
| Dexamethasone Generic | 19 | 19 | Under 11 | $126 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 17 | 17 | 15 | $219 |
| Megestrol Acetate Generic | 16 | 16 | Under 11 | $377 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 15 | 15 | Under 11 | $505 |
| Estradiol Generic | 15 | 25 | Under 11 | $985 |
| Eliquis Apixaban | 14 | 14 | Under 11 | $7,756 |
| Oxycodone Hcl Generic | 13 | 13 | Under 11 | $63.54 |
Brand drugs: 114 claims; generic drugs: 394 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John B Villeneuve $27.66 ($27.66 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $27.66.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $27.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.